Regeneron starts Phase 3 antibody testing as coronavirus cases surge
Just days after it pulled the plug on its rheumatoid arthritis drug to treat COVID-19, biotech company Regeneron said on Monday it was starting Phase III of its double-antibody treatment for the novel coronavirus.
Full story on FOX NEWS ( https://ift.tt/3f4QF5h )
No comments:
Post a Comment